Dr. Rosin is a physician-scientist. He completed a double major degree in Mathematics and Computer science (Suma Cum Laude in both majors) and worked as an R&D software engineer. After 3 years of experience in the tech industry, he has decided to pursue his life-long dream and started his MD degree at the Hebrew University of Jerusalem, Israel. There, searching for an intellectual challenge and a way to implement his previous experience in the medical field, he joined the MD-PhD program focusing on CNS electrophysiology and specifically Deep Brain Stimulation in Parkinson’s disease. His PhD project culminated in a Neuron publication describing a new method for DBS application, which is currently being explored in a clinical trial administered by Medtronic with his former PI, Professor Hagai Bergman. He has completed both MD and PhD degrees with distinction in 2013 and received numerous awards for his work.
Dr. Rosin completed his Ophthalmology residency and first vitreoretinal fellowship at the Hadassah-Hebrew University Medical Center, Jerusalem, Israel, where, under the supervision of Professor Eyal Banin, he almost immediately developed a keen interest in IRDs and assumed the role of the retinal electrophysiology unit co-director, together with Professor Banin. After completing his first fellowship, looking to broaden his surgical education and knowledge base of IRDs, he performed his second vitreoretinal fellowship at UPMC. Here, under the supervision of Dr. Sahel, he continued to be involved in the treatment and electrophysiological assessment of IRDs and received a thorough surgical training under the supervision of Dr. Eller and the attending physicians of the vitreoretinal service.
Dr. Rosin has served as an Assistant Professor of Ophthalmology at UPMC since 2021. He is a vitreoretinal surgeon performing all types of vitreoretinal surgery and seeing all types of retinal patients; however, his main interest remains the field of IRDs. He is the PI of a laboratory dedicated to studying the visual signal processing in the CNS of various animal models of IRDs. He is the local PI of two observational studies exploring the natural history of IRDs. His lab collaborates with many laboratories at the Vision Institute, providing functional assessment of visual function and functional vision in animal models visual disorders. He continues a close collaboration with Dr. Sahel on research and publications topics related to IRDs. Dr. Rosin is a recipient of the Career Development Award by the Foundation Fighting Blindness, the largest non-profit dedicated to patient care and the development of treatments for IRDs.
- UPMC Eye Center/Department of Ophthalmology, Research and Clinical Vitreo-Retinal Fellowship
- Hadassah Medical Center, Jerusalem, Vitreoretinal Fellowship
- Hadassah Medical Center, Jerusalem, Israeli Residency Program in Ophthalmology
- Hebrew University of Jerusalem, MD-PhD, with distinctions
- Tel Aviv University, Mathematics and Computer Science, Summa Cum Laude
Education & Training
Turning ON the inner retinal circuity: An exciting new approach to optogenetic therapy. Rosin B, Sahel JA. Mol Ther. 2025 Mar 5;33(3):840-841. doi: 10.1016/j.ymthe.2025.02.011. Epub 2025 Feb 24.
Best Disease: Global Mutations Review, Genotype-Phenotype Correlation, and Prevalence Analysis in the Israeli Population. Beryozkin A, Sher I, Ehrenberg M, Zur D, Newman H, Gradstein L, Simaan F, Rotenstreich Y, Goldenberg-Cohen N, Bahar I, Blumenfeld A, Rivera A, Rosin B, Deitch-Harel I, Perlman I, Mechoulam H, Chowers I, Leibu R, Ben-Yosef T, Pras E, Banin E, Sharon D, Khateb S. Invest Ophthalmol Vis Sci. 2024 Feb 1;65(2):39. doi: 10.1167/iovs.65.2.39.
An Optical Coherence Tomography-Based Measure as an Independent Estimate of Retinal Function in Retinitis Pigmentosa. Paez-Escamilla M, Alabek ML, Beale O, Prensky CJ, Lejoyeux R, Friberg TR, Sahel JA, Rosin B. Diagnostics (Basel). 2023 Nov 24;13(23):3521. doi: 10.3390/diagnostics13233521.
Tuned to Tremor: Increased Sensitivity of Cortico-Basal Ganglia Neurons to Tremor Frequency in the MPTP Nonhuman Primate Model of Parkinson's Disease. Rahamim N, Slovik M, Mevorach T, Linkovski O, Bergman H, Rosin B, Eitan R. J Neurosci. 2023 Nov 8;43(45):7712-7722. doi: 10.1523/JNEUROSCI.0529-23.2023. Epub 2023 Oct 13.
Current Status of Clinical Trials Design and Outcomes in Retinal Gene Therapy. Rosin B, Banin E, Sahel JA. Cold Spring Harb Perspect Med. 2024 Jul 1;14(7):a041301. doi: 10.1101/cshperspect.a041301.